Skip to main content
Trending storyHistorical stories

Araceli Biosciences raises $4.5M for cell-imaging drug testing

1 reports1 report sources3 days agoUpdate

Get up to speed on this story

AI Summary

Araceli Biosciences, a Portland-area biotech spun out of Phoseon Technology in 2023, has raised $4.5 million. The Tigard, Ore., company will use the funding to commercialize its cell imaging and analysis technology and develop new products that support testing new drugs on human cells instead of animal studies.

AI-generated from reports · 3 days agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 14
  1. GeekWireTop Deals
    Araceli Biosciences raises $4.5M for cell-imaging tools aimed at reducing animal testing

    Araceli Biosciences, a Tigard, Ore., startup spun out of Phoseon Technology in 2023.

Trend for this story

Comparable range current
3
Comparable range peak
10Nov 14 06:00
Change in the last 24 hours
-49%

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing